Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 2, 2008, Pages 213-219

  Xie, Song Qiang ^a   Hu, Guo Qiang ^a   Zhang, Zhong Quan ^a   Xu, Mei ^a   Ji, Bian Sheng ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACENE DERIVATIVE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; GLYCOPROTEIN P; HL 37; METALLOPROTEINASE; PROTEIN BCL XL; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL DEATH; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTHRACENES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; LEUKEMIA; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED ICR; P-GLYCOPROTEIN;

EID: 38949099327     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.2.0010     Document Type: Article

References (37)

1. Bu, X., Chen, J., Deady, L. W., Smith, C. L., Baguley, B. C., Greenhalgh, D., Yang, S., Denny, W. A. (2005) Synthesis and cytotoxic activity of N-[(alkylamino)alkyl]-carboxamide derivatives of 7-oxo-7H-benz[de]anthracene,7- oxo-7H-naphtho [1,2,3-de]quinoline, and 7-oxo-7Hbenzo[e]perimidine. Bioorg. Med. Chem. 13: 3657-3665
2. Chau, M., Christensen, J. L., Ajami, A. M., Capizzi, R. L. (2007) Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein- mediated efflux. Leuk. Res. 32: 1563-1572
3. Citarella, R. V., Wallace, R. E., Murdock, K. C., Angier, R. B., Durr, F. E., Forbes, M. (1982) Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Cancer Res. 42: 440-444
4. Czyz, M., Szulawska, A., Bednarek, A. K., Duchler, M. (2005) Effects of anthracycline derivatives on human leukemia K562 cell growth and differentiation. Biochem. Pharmacol. 70: 1431-1444
5. Egashira, M., Kawamata, N., Sugimoto, K., Kaneko, T., Oshimi, K. (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93: 599-606
6. Foroutan, B., Ruf, A. A., Jerwood, D., Anderson, D. (2007) An in vitro model to study chemoresistance in non-Hodgkin' s lymphoma patients over-expressing mutant p53. J. Pharmacol. Toxicol. Methods 55: 58-64
7. Gatouillat, G., Odot, J., Balasse, E., Nicolau, C., Tosi, P. F., Hickman, D. T., Lopez-Deber, M. P., Madoulet, C. (2007) Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells. Cancer Lett. 257: 165-171
8. Hu, G. Q., Xie, S. Q., Huang, W. L., Zhang, H. B. (2005) Synthesis and antibacterial activity of 8-substituted phenyl-1-pyridin-3-yl- 5H-bis[1,2,4]triazolo[3,4-b; 4′,3′-d][1,3,4] thiadiazines. Chin. Chem. Lett. 16: 723-726
9. Huang, Y., Keen, J. C., Hager, E., Smith, R., Hacker, A., Frydman, B., Valasinas, A. L., Reddy, V. K., Marion, L. J., Casero, R. A., Davidson, N. E. (2004) Regulation of polyamine analogue cytotoxicity by c-Jun in human MDA-MB435 cancer cells. Mol. Cancer Res. 2: 81-88
10. Ji, B. S., He, L. (2007) CJY, an isoflavone, reverses p-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. J. Pharm. Pharmacol. 59: 1011-1015
11. Ji, B. S., He, L., Liu, G. Q. (2005) Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life Sci. 77: 2221-2232
12. Jin, H. O., Yoon, S. I., Seo, S. K., Lee, H. C., Woo, S. H., Yoo, D. H., Lee, S. J., Choe, T. B., An, S., Kwon, T. J., Kim, J. I., Park, M. J., Hong, S. I., Park, I. C., Rhee, C. H. (2006) Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Biochem. Pharmacol. 72: 1228-1236
13. Kanofsky, J. R., Sima, P. D. (2000) Preferential cytotoxicity for multidrug-resistant K562 cells using the combination of a photosensitizer and a cyanine dye. J. Photochem. Photobiol. B: Biol. 54: 136-144
14. Kostakis, I. K., Tenta, R., Pouli, N., Marakos, P., Skaltsounis, A. L., Pratsinis, H., Kletsas, D. (2005) Design, synthesis, and antiproliferative activity of some novel aminosubstituted xanthenones, able to overcome multidrug resistance toward MES-SA/Dx5 cells. Bioorg. Med. Chem. Lett. 15: 5057-5060
15. Kostrzewa-Nowak, D., Paine, M. J., Korytowska, A., Serwatka, K., Piotrowska, S., Wolf, C. R., Tarasiuk, J. (2007) Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells. Cancer Lett. 245: 252-262
16. Kozurkova, M., Sabolova, D., Paulikova, H., Janovec, L., Kristian, P., Bajdichova, M., Busa, J., Podhradsky, D., Imrich, J. (2007) DNA binding properties and evaluation of activity of 9,10-bis-N-substituted (aminomethyl) anthracenes. Int. J. Biol. Macromol. 41: 415-422
17. Li, L., Lu, Q., Shen, Y., Hu, X. (2006) Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem. Pharmacol. 71: 584-595
18. Liu, J. J., Huang, T. S., Hsu, M. L., Chen, C. C., Lin, W. S., Lu, F. J., Chang, W. H. (2004) Antitumor effects of the partially purified polysaccharides from Antrodia camphorate and the mechanism of its action. Toxicol. Appl. Pharmacol. 201: 186-193
19. Min, J. K., Kim, J. H., Cho, Y. L., Maeng, Y. S., Lee, S. J., Pyun, B. J., Kim, Y. M., Park, J. H., Kwon, Y. G. (2006) 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem. Biophys. Res. Commun. 349: 987-994
20. Ozben, T. (2006) Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 580: 2903-2909
21. Pan, M. H., Huang, Y. T., Ho, C. T., Chang, C. I., Hsu, P. C., Pan, B. S. (2006) Induction of apoptosis by Meretrix lusoria though reactive oxygen species production, glutathione depletion, and caspase activation in human leukemia cells. Life Sci. 79: 1140-1152
22. Potter, A. J., Rabinovitch, P. S. (2005) The cell cycle phases of DNA-damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Mutat. Res. 572: 27-44
23. Pourpak, A., Landowski, T. H., Dorr, R. T. (2007) Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells. J. Pharmacol. Exp. Ther. 321: 1109-1117
24. Ren, D. D., Peng, G. H., Huang, H. X., Wang, H. B., Zhang, S. H. (2006) Effect of rhodoxanthin from Potamogeton crispus L. on cell apoptosis in Hea cells. Toxicol. In Vitro 20: 1411-1418
25. Salmon, S. E., Dalton, W. S., Grogan, T. M., Plezia, P., Lehnert, M., Roe, D. J., Miller, T. P. (1991) Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78: 44-50
26. Saponara, S., Ferrara, A., Gorelli, B., Shah, A., Kawase, M., Motohashi, N., Molnar, J., Sgaragli, G., Fusi, F. (2007) 3, 5-Dibenzoyl-4-(3-phenoxyphenyl) -1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart. Eur. J. Pharmacol. 563: 160-163
27. Tarasiuk, J., Majewska, E., Seksek, O., Rogacka, D., Antonini, I., Garnier-Suillerot, A., Borowski, E. (2004) The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines. Implications for overcoming multidrug resistance towards leukaemia K562/DOX cells. Biochem. Pharmacol. 68: 1815-182
28. Tarasiuk, J., Mazerski, J., Tkaczyk-Gobis, K., Borowski, E. (2005) Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies. Eur. J. Med. Chem. 40: 321-328
29. Wang, D. H., Wei, H. L., Zhao, H. S., Hao, C. Y., Min, Z. H., Liu, J. M. (2005) Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway. Pharmacol. Res. 52: 376-385
30. Wang, X., Wang, C., Qin, Y. W., Yan, S. K., Gao, Y. R. (2007a) Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells. Leuk. Res. 31: 989-994
31. Wang, X. H., Jia, D. Z., Liang, Y. J., Yan, S. L., Ding, Y., Chen, L. M., Shi, Z., Zeng, M. S., Liu, G. F., Fu, L. W. (2007b) Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway. Cancer Lett. 249: 256-270
32. Wunz, T. P., Craven, M. T., Karol, M. D., Hill, G. C., Remers, W. A. (1990) DNA binding by antitumor anthracene derivatives. J. Med. Chem. 33: 1549-1553
33. Yu, S. T., Chen, T. M., Tseng, S. Y., Chen, Y. H. (2007) Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem. Biophys. Res. Commun. 358: 79-84
34. Zhang, X. P., Ritke, M. K., Yalowich, J. C., Slovak, M. L., Ho, J. P., Collins, K. I., Annable, T., Arceci, R. J., Durr, F. E., Greenberger, L. M. (1994) P-glycoprotein mediates profound resistance to bisantrene. Oncol. Res. 6: 291-301
35. Zhang, G., Fang, L., Zhu, L., Zhong, Y., Wang, P. G., Sun, D. (2006) Syntheses and biological activities of 3′-azido disaccharide analogues of daunorubicin against drug-resistant leukemia. J. Med. Chem. 49: 1792-1799
36. Zhou, Y., Xu, Y., Tan, Y., Qi, J., Xiao, Y., Yang, C., Zhu, Z., Xiong, D. (2006) Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk. Res. 30: 469-476
37. Zhu, L., Cao, X., Chen, W., Zhang, G., Sun, D., Wang, P. G. (2005) Syntheses and biological activities of daunorubicin analogs with uncommon sugars. Biol. Med. Chem. 13: 6381-6387